new semaglutide medication Novo Nordisk's weight-loss pill wins FDA approval Ozempic® (semaglutide) GLP-1 RA for

P.et al (2001)

No one-size-fits-all approachyour dosage and plan are tailored to your unique goals and health profile

If you find that sugar cravings persist or become challenging to manage, consult your healthcare provider

Although the observed increase in risk is small on an individual level, the broad adoption of GLP1-RAs for weight management amplifies its potential implications at the population level, underscoring the need for heightened awareness among clinicians and patients about the dermatologic effects of these medications, the authors wrote

Clin Sci 2013;125:199210

But the drug, formerly known as Accutane, can have some serious side effects